Literature DB >> 27933685

The STOP-ACEi Trial - Apt timing for this long awaited randomised controlled trial - Validation of the syndrome of late-onset renal failure from angiotensin blockade (LORFFAB)?

Macaulay Amechi Chukwukadibia Onuigbo1,2.   

Abstract

Entities:  

Keywords:  STOP-ACEi Trial; angiotensin II receptor blocker; angiotensin-converting enzyme inhibitor; chronic kidney disease; late-onset renal failure from angiotensin blockade; randomised controlled trial; renal failure

Mesh：

Substances：

Year:  2016        PMID： 27933685     DOI： 10.1111/ijcp.12916

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN： 1368-5031            Impact factor:   2.503


× No keyword cloud information.
  2 in total

Review 1.  Diabetic nephropathy: Time to withhold development and progression - A review.

Authors:  Usama A A Sharaf El Din; Mona M Salem; Dina O Abdulazim
Journal:  J Adv Res       Date:  2017-04-21       Impact factor: 10.479

2.  Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?

Authors:  John M Brooks; Cole G Chapman; Manish Suneja; Mary C Schroeder; Michelle A Fravel; Kathleen M Schneider; June Wilwert; Yi-Jhen Li; Elizabeth A Chrischilles; Douglas W Brenton; Marian Brenton; Jennifer Robinson
Journal:  J Am Heart Assoc       Date:  2018-05-30       Impact factor: 5.501
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.